283 related articles for article (PubMed ID: 15370157)
21. Clinical laboratory evaluation of potential reduced exposure products for smokers.
Breland AB; Kleykamp BA; Eissenberg T
Nicotine Tob Res; 2006 Dec; 8(6):727-38. PubMed ID: 17132520
[TBL] [Abstract][Full Text] [Related]
22. No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia.
Bozikas VP; Niopas I; Kafantari A; Kanaze FI; Gabrieli C; Melissidis P; Gamvrula K; Fokas K; Karavatos A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):1-6. PubMed ID: 15610938
[TBL] [Abstract][Full Text] [Related]
23. [Cotinine--a useful biomarker for tobacco use?].
Suter PM; Spitzbarth A; Gautschi K; Erdmenger L; Vonderschmitt DJ; Vetter W
Praxis (Bern 1994); 1995 Jul; 84(29-30):821-5. PubMed ID: 7631097
[TBL] [Abstract][Full Text] [Related]
24. Using expired air carbon monoxide to determine smoking status during pregnancy: preliminary identification of an appropriately sensitive and specific cut-point.
Bailey BA
Addict Behav; 2013 Oct; 38(10):2547-50. PubMed ID: 23793041
[TBL] [Abstract][Full Text] [Related]
25. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers.
Feng S; Kapur S; Sarkar M; Muhammad R; Mendes P; Newland K; Roethig HJ
Toxicol Lett; 2007 Sep; 173(2):101-6. PubMed ID: 17716838
[TBL] [Abstract][Full Text] [Related]
26. [Application of the immunoassay for determination of cotinine in the urine].
Stanek A; Piekoszewski W; Florek E; Breborowicz GH; Anholcer A; Chuchracki M; Gomołka E; Kulza M; Kedziora H
Przegl Lek; 2007; 64(10):734-9. PubMed ID: 18409298
[TBL] [Abstract][Full Text] [Related]
27. Evaluating screening performances of the Fagerstrom tolerance questionnaire, the Fagerstrom test for nicotine dependence and the heavy smoking index among Taiwanese male smokers.
Huang CL; Lin HH; Wang HH
J Clin Nurs; 2008 Apr; 17(7):884-90. PubMed ID: 18321287
[TBL] [Abstract][Full Text] [Related]
28. [Determination of cotinine in human urine with gas chromatograph-mass spectrometry].
Cao M; Zhang YL; Jiang CQ; Lam TH; Cheng KK; Zhang WS
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):39-41. PubMed ID: 16600093
[TBL] [Abstract][Full Text] [Related]
29. Cotinine excretion (tobacco smoke biomarker) of smokers and non-smokers: comparison of GC/MS and RIA results.
Heinrich-Ramm R; Wegner R; Garde AH; Baur X
Int J Hyg Environ Health; 2002 Oct; 205(6):493-9. PubMed ID: 12455271
[TBL] [Abstract][Full Text] [Related]
30. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
[TBL] [Abstract][Full Text] [Related]
31. [Determination of nicotine and cotinine in human biological materials and their significance in toxicological studies].
Wiergowski M; Nowak-Banasik L; Morkowska A; Galer-Tatarowicz K; Szpiech B; Korolkiewicz R; Anand JS
Przegl Lek; 2006; 63(10):892-6. PubMed ID: 17288178
[TBL] [Abstract][Full Text] [Related]
32. [Select parameters of renal function in smokers in correlation with the exposure to cadmium].
Roszczenko A; Gałazyn-Sidorczuk M; Brzóska MM; Moniuszko-Jakoniuk J; Zwierz K
Przegl Lek; 2004; 61(4):348-50. PubMed ID: 15521599
[TBL] [Abstract][Full Text] [Related]
33. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy.
Jacob P; Hatsukami D; Severson H; Hall S; Yu L; Benowitz NL
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1668-73. PubMed ID: 12496059
[TBL] [Abstract][Full Text] [Related]
34. [Urinary cotinine and nicotine metabolites measurement].
Jacob N; Berny C; Boyer JC; Capolaghi B; de L'Homme G; Desch G; Garelik D; Houdret N; Le Moel G; Moulsma M; Plantin-Carrenard E
Ann Biol Clin (Paris); 2005; 63(4):397-409. PubMed ID: 16061438
[TBL] [Abstract][Full Text] [Related]
35. Nicotine exposure can be detected in cerebrospinal fluid of active and passive smokers.
Malkawi AH; Al-Ghananeem AM; de Leon J; Crooks PA
J Pharm Biomed Anal; 2009 Jan; 49(1):129-32. PubMed ID: 19036546
[TBL] [Abstract][Full Text] [Related]
36. [An assessment of cigarette smoking, with the usage of cotinine level, on life satisfaction in patients with coronary heart disease].
Nowak-Banasik L; Sein Anand J; Chodorowski Z; Wiergowski M; Sobiczewski W
Przegl Lek; 2007; 64(4-5):260-2. PubMed ID: 17724882
[TBL] [Abstract][Full Text] [Related]
37. Cigarette smoking: Evidence to guide measurement.
Stevens KR; Muñoz LR
Res Nurs Health; 2004 Aug; 27(4):281-92. PubMed ID: 15264266
[TBL] [Abstract][Full Text] [Related]
38. Salivary cotinine levels in human tobacco smokers predict the attentional validity effect size during smoking abstinence.
Shirtcliff EA; Marrocco RT
Psychopharmacology (Berl); 2003 Feb; 166(1):11-8. PubMed ID: 12491028
[TBL] [Abstract][Full Text] [Related]
39. [Concentration of cotinine and trans-3'-hydroxycotinine and its glucuronides in urine of smoking pregnant women].
Kedziora H; Florek E; Piekoszewski W; Breborowicz GH; Anholcer A; Gomółka E; Kulza M; Stanek A
Przegl Lek; 2007; 64(10):740-6. PubMed ID: 18409299
[TBL] [Abstract][Full Text] [Related]
40. Relative performance of common biochemical indicators in detecting cigarette smoking.
Marrone GF; Shakleya DM; Scheidweiler KB; Singleton EG; Huestis MA; Heishman SJ
Addiction; 2011 Jul; 106(7):1325-34. PubMed ID: 21438939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
